Please anonymize the following clinical note. Specifically, replace all the following information with the term “[redacted]”: redact any strings that might be a name or acronym or initial, redact any strings separated by the \/ symbol, redact patients' names, doctors' names and the strings in front of M.D. or after Dr., redact pager names and medical staff names, redact any strings that look like something years old or age 37, redact any dates and IDs and numbers and record dates, redact locations and addresses and clinic names, redact professions and ages and contacts, redact any acronyms and initials.: 



Record date: 2173-02-04


RADIATION ONCOLOGY FOLLOW-UP NOTE


HEATH, QUINTEN M. 805-94-75


REFERRING PHYSICIAN: Fred Quebedeaux, M.D.


DATE OF VISIT: 2/4/2173


REASON FOR VISIT: Reassessment of progress, s/p postoperative adjuvant radiation therapy in combination with concurrent chemotherapy for esophageal adenocarcinoma, T2N1 stage IIB, s/p left thoracoabdominal esophagectomy (12/01/69) with pathologic tumor stage T2N1M0 (3/23 involved lymph nodes).


POSTOPERATIVE RADIATION THERAPY:  For the presence of metastatic disease in regional lymph nodes, he was judged a candidate for postoperative adjuvant chemo-radiation therapy.  He was treated with a total dose of 45 Gy in 25 fractions to the tumor bed region using IMRT, planned with 4D CT simulation.  This treatment was administered in combination with chemotherapy between March 29, 2170, and Apr 30, 2170.  


HISTORY OF PRESENT ILLNESS: Mr. Quinten Heath is a 77 year-old gentleman with a history of smoking, chronic GERD, HTN, CAD s/p PCI, partially blocked L carotid artery and AAA repair x 2.  He was in his USOH until 8/69 when he began to have difficulty swallowing.  While eating a hamburger he felt it lodge in his chest with accompanying retrosternal discomfort and increased salivation.  He has had about a dozen similar episodes since then, which have generally resolved within 10-15 minutes without regurgitation.  In 9/69 his PCP prescribed a PPI, which helped somewhat, but he continued to have dysphagia.  On 10/16/69 EGD at Griffin Hospital demonstrated a partially-obstructing distal esophageal mass 34-39 cm from the incisors, associated with Barrett&#8217;s esophagus, with pathology significant for well differentiated invasive adenocarcinoma.  On 10/17/69 CT of the chest and abdomen showed prominent thickening of the distal esophagus.  On 10/21/69 repeat CT of the chest showed an 8 mm LLL nodule and R-sided pleural thickening.  Upper EUS showed a partially obstructing esophageal mass extending from 35-40 cm with 9 mm thickness, suggestive of invasion to the muscularis propria, one suspicious mediastinal LN, and porta hepatis adenopathy.  On 10/22 FNA of a porta hepatis LN was negative.


He underwent a left thoracoabdominal esophagectomy on 12/1/69. Pathology showed an ulcerated tumor measuring 4.0x3.5x0.8 cm, invading into muscularis propria (pT2) and metastasis to 3 of 27 LN (N1).  


INTERVAL HISTORY/REVIEW OF SYSTEMS: 
He has been doing well without significant GI or respiratory symptoms.
He has maintained steady energy and appetite.
He has had mild dysphagia for solid and meat. Otherwise, he has been doing well.
He denies significant respiratory symptoms. No focal or generalized neurological symptoms. The remainder of review of systems was unremarkable.


PAST MEDICAL HISTORY:
GERD x 20 years
HTN
Hypercholesterolemia
DM type II
CAD s/p stent 2164
Partially blocked L carotid
AAA repair 2165, 2167
Chronic bronchitis


CURRENT MEDICATIONS:
Aspirin (ACETYLSALICYLIC ACID) 325 MG (325MG TABLET Take 1) PO QD 
Caltrate 600 + D (CALCIUM CARBONATE 1500 MG (600 MG ELEM CA)/ VIT D 200 IU) 1 TAB PO BID 
Centrum SILVER (MULTIVITAMINS) 1 TAB PO QD 
Isosorbide 30 MG 1/2 TAB PO bid 
Metformin 250 MG (500MG TABLET Take 0.5) PO QD 
Metoprolol SUCCINATE EXTENDED RELEASE 50 MG (50MG TAB.SR 24H Take 1) PO QD 
Plavix (CLOPIDOGREL) 75 MG (75MG TABLET Take 1) PO QD 
Prilosec (OMEPRAZOLE) 20 MG (20 MG CAPSULE DR Take 1) PO QD 
Reclast (ZOLEDRONIC ACID ) 4 MG (4MG/5ML VIAL Take 5 ML) IV once a year , given 6/25/72
Simvastatin 20 MG (20 MG TABLET Take 1) PO QPM 
Tricor (FENOFIBRATE (TRICOR)) 134 MG (134MG CAPSULE Take 1) PO QD 
Vitamin C (ASCORBIC ACID) 500 MG PO qd 
Zoloft (SERTRALINE) 50 MG (50MG TABLET Take 1) PO QD #30 Tablet(s)



ALLERGIES:
Adhesive tape (rash)


SOCIAL HISTORY:
Lives with wife in Gardnerville Ranchos, GA.  3 healthy adult children.
Retired 2158 as a Producer for National Radi and Access Amer..
Quit smoking 2153, prior &#189;-1 ppd x 30 years.
Rare social alcohol.


FAMILY HISTORY:
Mother, MI, died age 65.
Father, died age 89.
Brother and sister, no cancer.


PHYSICAL EXAMINATION:
General:  pleasant elderly gentleman, NAD
ECOG PS: 1
Vital Signs: 
BP 118/78, P 72, RR 16, Temp 97.3 F, Ht 64.75 in, Wt 137.5 lb
O2 SAT 97 
BMI 23.1 
PAIN LEVEL (0-10) 0 
HEENT:  PERRL, EOMI, MMM, OP clear
Neck:  supple, no JVD.
Nodes:  no cervical or supraclavicular LAD
Chest:  Clear without wheezes or rales. 
Heart:  RRR, no m/r/g
Abdomen:  soft, NT/ND, no HSM, NABS, well-healed scar from AAA repair
Ext:  no edema or tenderness. 
Skin:  Unremarkable. 
Neuro:  AOx3, nonfocal


RADIOGRAPHIC STUDIES:
CT Chest/Abdomen/Pelvis 2/2173
CT Chest/Abdomen/Pelvis 12/2169
CT Chest/Abdomen/Pelvis 10/2169
EGD 10/2169
EGD 10/2168
EGD 10/2167
EGD 10/2166
EGD 10/2165
EGD 10/2164
EGD 10/2163
EGD 10/2162
EGD 10/2161
EGD 10/2160
EGD 10/2159
EGD 10/2158
EGD 10/2157
EGD 10/2156
EGD 10/2155
EGD 10/2154
EGD 10/2153
EGD 10/2152
EGD 10/2151
EGD 10/2150
EGD 10/2149
EGD 10/2148
EGD 10/2147
EGD 10/2146
EGD 10/2145
EGD 10/2144
EGD 10/2143
EGD 10/2142
EGD 10/2141
EGD 10/2140
EGD 10/2139
EGD 10/2138
EGD 10/2137
EGD 10/2136
EGD 10/2135
EGD 10/2134
EGD 10/2133
EGD 10/2132
EGD 10/2131
EGD 10/2130
EGD 10/2129
EGD 10/2128
EGD 10/2127
EGD 10/2126
EGD 10/2125
EGD 10/2124
EGD 10/2123
EGD 10/2122
EGD 10/2121
EGD 10/2120
EGD 10/2119
EGD 10/2118
EGD 10/2117
EGD 10/2116
EGD 10/2115
EGD 10/2114
EGD 10/2113
EGD 10/2112
EGD 10/2111
EGD 10/2110
EGD 10/2109
EGD 10/2108
EGD 10/2107
EGD 10/2106
EGD 10/2105
EGD 10/2104
EGD 10/2103
EGD 10/2102
EGD 10/2101
EGD 10/2100
EGD 10/2099
EGD 10/2098
EGD 10/2097
EGD 10/2096
EGD 10/2095
EGD 10/2094
EGD 10/2093
EGD 10/2092
EGD 10/2091
EGD 10/2090
EGD 10/2089
EGD 10/2088
EGD 10/2087
EGD 10/2086
EGD 10/2085
EGD 10/2084
EGD 10/2083
EGD 10/2082
EGD 10/2081
EGD 10/2080
EGD 10/2079
EGD 10/2078
EGD 10/2077
EGD 10/2076
EGD 10/2075
EGD 10/2074
EGD 10/2073
EGD 10/2072
EGD 10/2071
EGD 10/2070
EGD 10/2069
EGD 10/2068
EGD 10/2067
EGD 10/2066
EGD 10/2065
EGD 10/2064
EGD 10/2063
EGD 10/2062
EGD 10/2061
EGD 10/2060
EGD 10/2059
EGD 10/2058
EGD 10/2057
EGD 10/2056
EGD 10/2055
EGD 10/2054
EGD 10/2053
EGD 10/2052
EGD 10/2051
EGD 10/2050
EGD 10/2049
EGD 10/2048
EGD 10/2047
EGD 10/2046
EGD 10/2045
EGD 10/2044
EGD 10/2043
EGD 10/2042
EGD 10/2041
EGD 10/2040
EGD 10/2039
EGD 10/2038
EGD 10/2037
EGD 10/2036
EGD 10/2035
EGD 10/2034
EGD 10/2033
EGD 10/2032
EGD 10/2031
EGD 10/2030
EGD 10/2029
EGD 10/2028
EGD 10/2027
EGD 10/2026
EGD 10/2025
EGD 10/2024
EGD 10/2023
EGD 10/2022
EGD 10/2021
EGD 10/2020
EGD 10/2019
EGD 10/2018
EGD 10/2017
EGD 10/2016
EGD 10/2015
EGD 10/2014
EGD 10/2013
EGD 10/2012
EGD 10/2011
EGD 10/2010
EGD 10/2009
EGD 10/2008
EGD 10/2007
EGD 10/2006
EGD 10/2005
EGD 10/2004
EGD 10/2003
EGD 10/2002
EGD 10/2001
EGD 10/2000
EGD 10/1999
EGD 10/1998
EGD 10/1997
EGD 10/1996
EGD 10/1995
EGD 10/1994
EGD 10/1993
EGD 10/1992
EGD 10/1991
EGD 10/1990
EG